Insider · CIK 0001303643

YOUNG KEVIN

Reports to the SEC for 2 companies · FOSTER CITY, CA

sec.gov

Transactions

Companies

Filings

CIK

0001303643

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2020-06-08	IRLAIRulya Therapeutics Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+11K sh	—	—	11,029
2019-05-13	IRLAIRulya Therapeutics Inc.P Purchase	Director	PPurchase	+30K sh	$17.00	+$510K	30,000
2018-02-21	GILDGILEAD SCIENCES, INC.A Award	Chief Operating Officer	AAward	+9,460 sh	—	—	25,612
2018-02-15	GILDGILEAD SCIENCES, INC.A Award	Chief Operating Officer	AAward	+340 sh	$62.35	+$21.2K	16,152
2018-02-10	GILDGILEAD SCIENCES, INC.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+908 sh	—	—	16,237
2018-02-10	GILDGILEAD SCIENCES, INC.F Tax Payment	Chief Operating Officer	FTax Payment	−425 sh	$79.32	−$33.7K	15,812
2018-02-10	GILDGILEAD SCIENCES, INC. · Restricted Stock UnitM Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−908 sh	—	—	3,184
2018-02-01	GILDGILEAD SCIENCES, INC.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+620 sh	—	—	15,547
2018-02-01	GILDGILEAD SCIENCES, INC.F Tax Payment	Chief Operating Officer	FTax Payment	−218 sh	$83.49	−$18.2K	15,329
2018-02-01	GILDGILEAD SCIENCES, INC. · Restricted Stock UnitM Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−620 sh	—	—	4,092
2018-01-31	GILDGILEAD SCIENCES, INC.A Award	Chief Operating Officer	AAward	+7,110 sh	—	—	17,186
2018-01-31	GILDGILEAD SCIENCES, INC.F Tax Payment	Chief Operating Officer	FTax Payment	−2,259 sh	$83.80	−$189K	14,927
2017-11-09	GILDGILEAD SCIENCES, INC.A Award	Chief Operating Officer	AAward	+6,810 sh	—	—	13,498
2017-11-09	GILDGILEAD SCIENCES, INC.F Tax Payment	Chief Operating Officer	FTax Payment	−3,422 sh	$73.02	−$250K	10,076
2017-08-10	GILDGILEAD SCIENCES, INC.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+910 sh	—	—	7,141
2017-08-10	GILDGILEAD SCIENCES, INC.F Tax Payment	Chief Operating Officer	FTax Payment	−453 sh	$72.70	−$32.9K	6,688
2017-08-10	GILDGILEAD SCIENCES, INC. · Restricted Stock UnitM Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−910 sh	—	—	4,712
2017-05-10	GILDGILEAD SCIENCES, INC.A Award	Chief Operating Officer	AAward	+6,810 sh	—	—	9,691
2017-05-10	GILDGILEAD SCIENCES, INC.F Tax Payment	Chief Operating Officer	FTax Payment	−3,460 sh	$66.92	−$232K	6,231
2017-02-15	GILDGILEAD SCIENCES, INC.A Award	Chief Operating Officer	AAward	+315 sh	$59.33	+$18.7K	2,881
2017-02-10	GILDGILEAD SCIENCES, INC.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+908 sh	—	—	2,883
2017-02-10	GILDGILEAD SCIENCES, INC.F Tax Payment	Chief Operating Officer	FTax Payment	−317 sh	$66.36	−$21K	2,566
2017-02-10	GILDGILEAD SCIENCES, INC. · Restricted Stock UnitM Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−908 sh	—	—	5,622
2017-02-02	GILDGILEAD SCIENCES, INC. · Non-qualified Stock Option (Right to Buy)A Award	Chief Operating Officer	AAward	+116K sh	$72.25	+$8.37M	115,870
2017-02-01	GILDGILEAD SCIENCES, INC.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+620 sh	—	—	2,190
2017-02-01	GILDGILEAD SCIENCES, INC.F Tax Payment	Chief Operating Officer	FTax Payment	−215 sh	$72.82	−$15.7K	1,975
2017-02-01	GILDGILEAD SCIENCES, INC. · Restricted Stock UnitM Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−620 sh	—	—	6,530
2016-08-10	GILDGILEAD SCIENCES, INC.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+910 sh	—	—	2,036
2016-08-10	GILDGILEAD SCIENCES, INC.F Tax Payment	Chief Operating Officer	FTax Payment	−466 sh	$78.90	−$36.8K	1,570
2016-08-10	GILDGILEAD SCIENCES, INC. · Restricted Stock UnitM Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−910 sh	—	—	7,150
2016-06-10	GILDGILEAD SCIENCES, INC. · Non-qualified Stock Option (Right to Buy)A Award	Chief Operating Officer	AAward	+83.9K sh	—	—	83,880
2014-02-01	GILDGILEAD SCIENCES, INC. · Non-Qualified Stock Option (right to buy)A Award	Chief Operating Officer	AAward	+8,250 sh	—	—	8,250
2014-02-01	GILDGILEAD SCIENCES, INC. · Restricted Stock UnitsA Award	Chief Operating Officer	AAward	+2,480 sh	—	—	2,480
2014-02-01	GILDGILEAD SCIENCES, INC. · Performance SharesD Disposition to Issuer	Chief Operating Officer	DDisposition to Issuer	−11.1K sh	—	—	153,931
2014-01-23	GILDGILEAD SCIENCES, INC.A Award	Chief Operating Officer	AAward	+21.3K sh	—	—	204,506
2014-01-23	GILDGILEAD SCIENCES, INC.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+100K sh	$16.39	+$1.64M	316,418
2014-01-23	GILDGILEAD SCIENCES, INC.S Sale	Chief Operating Officer	SSale	−100K sh	$81.44	−$8.14M	216,418
2014-01-23	GILDGILEAD SCIENCES, INC. · Non-Qualified Stock Optin (right to buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−100K sh	—	—	107,508
2014-01-23	GILDGILEAD SCIENCES, INC.A Award	Chief Operating Officer	AAward	+11.9K sh	—	—	216,418
2013-12-20	GILDGILEAD SCIENCES, INC.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+75K sh	$16.39	+$1.23M	236,840
2013-12-20	GILDGILEAD SCIENCES, INC.S Sale	Chief Operating Officer	SSale	−75K sh	$74.19	−$5.56M	161,840
2013-12-20	GILDGILEAD SCIENCES, INC. · Non-Qualified Stock Optin (right to buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−75K sh	—	—	207,508
2013-11-22	GILDGILEAD SCIENCES, INC.S Sale	Chief Operating Officer	SSale	−38K sh	$74.77	−$2.84M	161,840
2013-11-22	GILDGILEAD SCIENCES, INC. · Non-Qualified Stock Optin (right to buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−75K sh	—	—	282,508
2013-11-22	GILDGILEAD SCIENCES, INC.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+75K sh	$16.39	+$1.23M	236,840
2013-11-22	GILDGILEAD SCIENCES, INC.S Sale	Chief Operating Officer	SSale	−37K sh	$73.90	−$2.73M	199,840
2013-10-23	GILDGILEAD SCIENCES, INC.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+75K sh	$16.39	+$1.23M	236,840
2013-10-23	GILDGILEAD SCIENCES, INC.S Sale	Chief Operating Officer	SSale	−72.5K sh	$68.54	−$4.97M	164,340
2013-10-23	GILDGILEAD SCIENCES, INC.S Sale	Chief Operating Officer	SSale	−2,500 sh	$69.20	−$173K	161,840
2013-10-23	GILDGILEAD SCIENCES, INC. · Non-Qualified Stock Optin (right to buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−75K sh	—	—	357,508

Recent filings

Accepted (ET)
Jun 94
YOUNG KEVIN0001209191-20-035425
SEC(opens sec.gov)
Mar 124
YOUNG KEVIN0001209191-20-018558
SEC(opens sec.gov)
Feb 234
YOUNG KEVIN0001127602-18-008135
SEC(opens sec.gov)
Feb 134
YOUNG KEVIN0001127602-18-005553
SEC(opens sec.gov)
Feb 24
YOUNG KEVIN0001127602-18-003872
SEC(opens sec.gov)
Nov 134
YOUNG KEVIN0001127602-17-031968
SEC(opens sec.gov)
Aug 144
YOUNG KEVIN0001127602-17-025602
SEC(opens sec.gov)
May 124
GILEAD SCIENCES INC0001127602-17-017962
SEC(opens sec.gov)
Feb 214
GILEAD SCIENCES INC0001127602-17-007543
SEC(opens sec.gov)

Companies

Address

GILEAD SCIENCES, INC. 333 LAKESIDE DRIVE

FOSTER CITY, CA, 94404